Li Ma1,2,3, Na Zhou2, Rongjun Zou2, Wanting Shi4, Yuanyuan Luo3, Na Du5, Jing Zhong5, Xiaodong Zhao3, Xinxin Chen2, Huimin Xia1,3, Yueheng Wu6,7. 1. The First Affiliated Hospital of Jinan University, Guangzhou, China. 2. Heart Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. 3. Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. 4. Department of Paediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. 5. Department of Surgical Nursing, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. 6. Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangzhou, China. 7. Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Abstract
OBJECTIVE: To probe markers and molecular mechanisms of the hypoplastic left heart (HLH) by single-cell RNA sequencing (scRNA-seq) and quantitative proteomics analysis. METHODS: Following data preprocessing, scRNA-seq data of pluripotent stem cell (iPSC)-derived cardiomyocytes from one HLH patient and one control were analyzed by the Seurat package in R. Cell clusters were characterized, which was followed by a pseudotime analysis. Markers in the pseudotime analysis were utilized for functional enrichment analysis. Quantitative proteomics analysis was based on peripheral blood samples from HLH patients without heart failure (HLH-NHF), HLH patients with heart failure (HLH-HF), and healthy controls. Hub genes were identified by the intersection of pseudotime markers and differentially expressed proteins (DE-proteins), which were validated in the GSE77798 dataset, RT-qPCR, and western blot. RESULTS: Cardiomyocytes derived from iPSCs were clustered into mesenchymal stem cells, myocardium, and fibroblast cells. Pseudotime analysis revealed their differentiation trajectory. Markers in the three pseudotime clusters were significantly associated with distinct biological processes and pathways. Finally, three hub genes (MMP2, B2M, and COL5A1) were identified, which were highly expressed in the left (LV) and right (RV) ventricles of HLH patients compared with controls. Furthermore, higher expression levels were detected in HLH patients with or without HF than in controls. CONCLUSION: Our findings elucidate marker genes and molecular mechanisms of HLH, deepening the understanding of the pathogenesis of HLH.
OBJECTIVE: To probe markers and molecular mechanisms of the hypoplastic left heart (HLH) by single-cell RNA sequencing (scRNA-seq) and quantitative proteomics analysis. METHODS: Following data preprocessing, scRNA-seq data of pluripotent stem cell (iPSC)-derived cardiomyocytes from one HLH patient and one control were analyzed by the Seurat package in R. Cell clusters were characterized, which was followed by a pseudotime analysis. Markers in the pseudotime analysis were utilized for functional enrichment analysis. Quantitative proteomics analysis was based on peripheral blood samples from HLH patients without heart failure (HLH-NHF), HLH patients with heart failure (HLH-HF), and healthy controls. Hub genes were identified by the intersection of pseudotime markers and differentially expressed proteins (DE-proteins), which were validated in the GSE77798 dataset, RT-qPCR, and western blot. RESULTS: Cardiomyocytes derived from iPSCs were clustered into mesenchymal stem cells, myocardium, and fibroblast cells. Pseudotime analysis revealed their differentiation trajectory. Markers in the three pseudotime clusters were significantly associated with distinct biological processes and pathways. Finally, three hub genes (MMP2, B2M, and COL5A1) were identified, which were highly expressed in the left (LV) and right (RV) ventricles of HLH patients compared with controls. Furthermore, higher expression levels were detected in HLH patients with or without HF than in controls. CONCLUSION: Our findings elucidate marker genes and molecular mechanisms of HLH, deepening the understanding of the pathogenesis of HLH.
Authors: Carmen C Sucharov; Juliana Sucharov; Anis Karimpour-Fard; Karin Nunley; Brian L Stauffer; Shelley D Miyamoto Journal: J Card Fail Date: 2014-10-05 Impact factor: 5.712
Authors: Melanie D Everitt; Gerard J Boyle; Kenneth B Schechtman; Jie Zheng; Emily A Bullock; Aditya K Kaza; Anne I Dipchand; David C Naftel; James K Kirklin; Charles E Canter Journal: J Heart Lung Transplant Date: 2012-02-09 Impact factor: 10.247
Authors: Daniel A Skelly; Galen T Squiers; Micheal A McLellan; Mohan T Bolisetty; Paul Robson; Nadia A Rosenthal; Alexander R Pinto Journal: Cell Rep Date: 2018-01-16 Impact factor: 9.423
Authors: Ruwan A Weerakkody; Jana Vandrovcova; Christina Kanonidou; Michael Mueller; Piyush Gampawar; Yousef Ibrahim; Penny Norsworthy; Jennifer Biggs; Abdulshakur Abdullah; David Ross; Holly A Black; David Ferguson; Nicholas J Cheshire; Hanadi Kazkaz; Rodney Grahame; Neeti Ghali; Anthony Vandersteen; F Michael Pope; Timothy J Aitman Journal: Genet Med Date: 2016-03-24 Impact factor: 8.822
Authors: Sergio A Carrillo; Karen M Texter; Christina Phelps; Yubo Tan; Patrick I McConnell; Mark Galantowicz Journal: World J Pediatr Congenit Heart Surg Date: 2020-08-12
Authors: Táňa Andreasová; Jana Vránová; Dagmar Vondráková; Lenka Sedláčková; Zuzana Jirásková Zákostelská; Petr Neužil; Filip Málek Journal: J Int Med Res Date: 2020-08 Impact factor: 1.671